Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA reform legislation from Senate before month-end

This article was originally published in Clinica

Executive Summary

The Senate bill for FDA reform is due to be introduced to Congress before the end of the month. Senator Nancy Kassenbaum intends to introduce the FDA Performance and Accountability Act 1995 before the Thanksgiving recess (November 23rd). Designed to streamline the review process, the bill contains many elements for agency reform debated earlier in the year and which have been incorporated into the House bill (see Clinica No 659, p 6).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094081

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel